within Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L01A_AlkylatingAgents.L01AB02_Treosulfan;
model Treosulfan 
   extends Pharmacolibrary.Drugs.ATC.L.L01AB02;

  annotation(Documentation(
    info ="<html><body><p>Treosulfan is an alkylating agent used in conditioning regimens prior to hematopoietic stem cell transplantation (HSCT), mainly for treatment of hematological malignancies and some non-malignant diseases. It is currently approved and in clinical use in several countries for both adults and children as a part of preparative regimens for transplantation.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in adult patients undergoing allogeneic stem cell transplantation receiving intravenous treosulfan. Mean values from population PK analyses.</p><h4>References</h4><ol><li><p>Główka, F, et al., &amp; Żaba, C (2015). Pharmacokinetics of treosulfan and its active monoepoxide in pediatric patients after intravenous infusion of high-dose treosulfan prior to HSCT. <i>European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences</i> 68 87–93. DOI:<a href=&quot;https://doi.org/10.1016/j.ejps.2014.12.010&quot;>10.1016/j.ejps.2014.12.010</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/25527118/&quot;>https://pubmed.ncbi.nlm.nih.gov/25527118</a></p></li><li><p>Rosser, SPA, et al., &amp; Nath, CE (2023). Evaluation of treosulfan cumulative exposure in paediatric patients through population pharmacokinetics and dosing simulations. <i>British journal of clinical pharmacology</i> 89(4) 1413–1424. DOI:<a href=&quot;https://doi.org/10.1111/bcp.15599&quot;>10.1111/bcp.15599</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36369677/&quot;>https://pubmed.ncbi.nlm.nih.gov/36369677</a></p></li><li><p>Główka, FK, et al., &amp; Wachowiak, J (2008). Pharmacokinetics of high-dose i.v. treosulfan in children undergoing treosulfan-based preparative regimen for allogeneic haematopoietic SCT. <i>Bone marrow transplantation</i> 42 Suppl 2 S67–S70. DOI:<a href=&quot;https://doi.org/10.1038/bmt.2008.287&quot;>10.1038/bmt.2008.287</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/18978748/&quot;>https://pubmed.ncbi.nlm.nih.gov/18978748</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Treosulfan;
